Successful Transduction with AAV Vectors after Selective Depletion of Anti-AAV Antibodies by Immunoadsorption

Gene therapy with adeno-associated virus (AAV)-based vectors shows great promise for the gene therapeutic treatment of a broad array of diseases. In fact, the treatment of genetic diseases with AAV vectors is currently the only in vivo gene therapy approach that is approved by the US Food and Drug A...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlowski, Alejandro, Katz, Michael G., Gubara, Sarah M., Fargnoli, Anthony S., Fish, Kenneth M., Weber, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011017/
https://www.ncbi.nlm.nih.gov/pubmed/32055647
http://dx.doi.org/10.1016/j.omtm.2020.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011017/
https://www.ncbi.nlm.nih.gov/pubmed/32055647
http://dx.doi.org/10.1016/j.omtm.2020.01.004

Ejemplares similares